Optimization of the immune response against transferrin receptor based vaccines

The bacterial transferrin receptor is considered to be a potentially efficacious candidate vaccine antigen against pathogens important in human disease and in animal husbandry. Previous data suggests that transferrin receptor-based antigens can elicit protection from both invasive disease and potentially from asymptomatic colonization. One major consideration when developing vaccines is the choice of adjuvant, a […]

Read More
Novel membrane mimetics in HT antibody screening and structural biology

Many therapeutic targets are proteins embedded in the membrane that surrounds the cell. Traditionally, such targets present major challenges, because they required the use of detergents to extract them from the membrane and to purify them. Such detergents can cause artefacts, hampering the development of novel therapeutics. Here we will test new methods that get […]

Read More
Analysis of TGF-? traps as effective immunostimulating cancer treatments

AVID200 is a TGF-? trap that specifically sequesters TGF-?I and TGF-?III to enhance antitumour immunity to inhibit tumor growth. AVID200 also avoids adverse side effect of depleted of TGF-?II. AVID200 is relatively short-lived in circulation, decreasing its capacity to exert desirable enhancement of anti-tumour immunity. To increase the effectiveness of TGF-? traps, a panel of […]

Read More
Preparation and testing of a sawdust-based phosphate filtration matrix

High concentrations of phosphate in the waterways cause algae blooms which are detrimental to water quality and fish habitat. The research project conducted by the Department of Chemistry & Biochemistry and the Upper Thames River Conservation authority, is attempting to alleviate this problem by chemically altering sawdust so that it can act as a phosphate […]

Read More
Design and advancement of Graft Enabled Antibody Therapies (GrEAT) – Year 2

Membrane proteins such as ion channels, transporters or G-protein coupled receptors (GPCRs) are excellent but difficult drug targets involved in a large number of life-threatening diseases and conditions. These proteins, over-expressed and essential for disease onset and progression, are naturally targeted by toxins from venomous organisms. During evolution, these toxins have been optimized to efficiently […]

Read More
Assessment of Salmonella enterica and Campylobacter jejuni inhibition using lead single domain antibodies in combination with dysregulators of the master protease ClpP

The human pathogenic bacteria Salmonella enterica and Campylobacter jejuni are commonly found in the intestine of poultry. Consumption of infected chicken and eggs, and its derivatives, is the main and most important source of infection outbreaks in humans causing diarrhoea, fevers and abdominal cramps. In some cases, severe diarrhea and dehydration followed by systemic spreading […]

Read More
Development of Fungal-Specific Stress Response Inhibitors for the Treatment of Fungal Infections

Drug resistance of medically relevant microorganisms poses a grave threat to human health and has severe economic consequences. Fungal pathogens pose an additional complication as they are closely related to their human host. Current therapies to treat fungal infections are limited and drug resistance has already emerged in the clinic. We have conducted extensive research […]

Read More
Effects of Chemotherapy and Immune Cells on Ribosomal RNA Degradation (RNA disruption) in Tumour Cells

The business partner in this application (Rna Diagnostics, Inc.) has developed a diagnostic tool to determine whether the tumour(s) of a cancer patient undergoing chemotherapy before surgery is responding (dying) in response to treatment. This tool, called the Rna Disruption Assay (RDA), can help tailor chemotherapy, such that chemotherapy treatment is discontinued (along with its […]

Read More
Evaluation of NanoDendrixTM stability; phytoglycogen resilience in simulated oral cavity conditions

NanoDendrix™ is a completely natural form of glycogen, sourced and produced from plants by a patented green process developed in Guelph, Ontario. Recent studies have revealed many valuable properties and performance characteristics of NanoDendrix, such as its antimicrobial effects, which have wide-ranging implications for clinical use. The proposed internship will evaluate NanoDendrix for use in […]

Read More
Developing biomarker identification tools for neurodegenerative diseases

Neurodegenerative diseases have caused massive economic burden on the healthcare system as well as reduced patient and caregiver’s quality of life. Identifying biomarkers for early clinical diagnosis, tracking of disease progression, and evaluation of treatment therapies is critical. However, developing such tools remains a significant challenge. The goal of this project is to manage and […]

Read More